GPR27 Regulates Hepatocellular Carcinoma Progression via MAPK/ERK Pathway

References

• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424. doi:10.3322/caac.21492
   PubMed Web of Science ®Google Scholar
• McGuire S. World cancer report 2014. Geneva, Switzerland: world health organization, international agency for research on cancer, who press, 2015. Adv Nutr. 2016;7:418–419. doi:10.3945/an.116.012211
   PubMed Web of Science ®Google Scholar
• Yang JD, Hainaut P, Gores GJ, et al. A global view of hepatocellular carcinoma: trends, risk, prevention and management. Nat Rev Gastroenterol Hepatol. 2019;16:589–604. doi:10.1038/s41575-019-0186-y
   PubMed Web of Science ®Google Scholar
• Vos T, Allen C, Arora M, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the global burden of disease study 2015. Lancet. 2016;388:1545–1602. doi:10.1016/S0140-6736(16)31678-6
   PubMed Web of Science ®Google Scholar
• Kudo M, Finn RS, Qin S, et al. Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised Phase 3 non-inferiority trial. Lancet. 2018;391:1163–1173. doi:10.1016/S0140-6736(18)30207-1
   PubMed Web of Science ®Google Scholar
• Keating GM. Sorafenib: a review in hepatocellular carcinoma. Target Oncol. 2017;12:243–253. doi:10.1007/s11523-017-0484-7
   PubMed Web of Science ®Google Scholar
• Huang A, Yang X-R, Chung W-Y, et al. Targeted therapy for hepatocellular carcinoma. Signal Transduct Target Ther. 2020;5:146. doi:10.1038/s41392-020-00264-x
   PubMed Web of Science ®Google Scholar
• Venkatakrishnan A, Deupi X, Lebon G, et al. Molecular signatures of g-protein-coupled receptors. Nature. 2013;494:185–194. doi:10.1038/nature11896
   PubMed Web of Science ®Google Scholar
• Rosenbaum DM, Rasmussen SG, Kobilka BK. The structure and function of g-protein-coupled receptors. Nature. 2009;459:356–363. doi:10.1038/nature08144
   PubMed Web of Science ®Google Scholar
• Ritter SL, Hall RA. Fine-tuning of gpcr activity by receptor-interacting proteins. Nat Rev Mol Cell Biol. 2009;10:819–830. doi:10.1038/nrm2803
   PubMed Web of Science ®Google Scholar
• Wang D. The essential role of g protein-coupled receptor (gpcr) signaling in regulating t cell immunity. Immunopharmacol Immunotoxicol. 2018;40:187–192. doi:10.1080/08923973.2018.1434792
   PubMed Web of Science ®Google Scholar
• Li S, Yang C, Zhang L, et al. Promoting axon regeneration in the adult cns by modulation of the melanopsin/gpcr signaling. Proc Nat Acad Sci. 2016;113:1937–1942. doi:10.1073/pnas.1523645113
   PubMed Web of Science ®Google Scholar
• Husted AS, Trauelsen M, Rudenko O, et al. Gpcr-mediated signaling of metabolites. Cell Metab. 2017;25:777–796. doi:10.1016/j.cmet.2017.03.008
   PubMed Web of Science ®Google Scholar
• Hazell GG, Hindmarch CC, Pope GR, et al. G protein-coupled receptors in the hypothalamic paraventricular and supraoptic nuclei–serpentine gateways to neuroendocrine homeostasis. Front Neuroendocrinol. 2012;33:45–66. doi:10.1016/j.yfrne.2011.07.002
   PubMed Web of Science ®Google Scholar
• Joost P, Methner A. Phylogenetic analysis of 277 human g-protein-coupled receptors as a tool for the prediction of orphan receptor ligands. Genome Biol. 2002;3:RESEARCH0063–RESEARCH0063. doi:10.1186/gb-2002-3-11-research0063
   PubMed Web of Science ®Google Scholar
• Hu G-M, Mai T-L, Chen C-M. Visualizing the gpcr network: classification and evolution. Sci Rep. 2017;7:15495. doi:10.1038/s41598-017-15707-9
   PubMed Web of Science ®Google Scholar
• Odoemelam CS, Percival B, Wallis H, et al. G-protein coupled receptors: structure and function in drug discovery. RSC Adv. 2020;10:36337–36348. doi:10.1039/D0RA08003A
   PubMed Web of Science ®Google Scholar
• Niss Arfelt K, Fares S, Sparre-Ulrich AH. Signaling via g proteins mediates tumorigenic effects of gpr87. Cell Signal. 2017;30:9–18. doi:10.1016/j.cellsig.2016.11.009
   PubMed Web of Science ®Google Scholar
• Brown TP, Bhattacharjee P, Ramachandran S. The lactate receptor gpr81 promotes breast cancer growth via a paracrine mechanism involving antigen-presenting cells in the tumor microenvironment. Oncogene. 2020;39:3292–3304. doi:10.1038/s41388-020-1216-5
   PubMed Web of Science ®Google Scholar
• Cherry AE, Vicente JJ, Xu C. Gpr124 regulates microtubule assembly, mitotic progression, and glioblastoma cell proliferation. Glia. 2019;67:1558–1570. doi:10.1002/glia.23628
   PubMed Web of Science ®Google Scholar
• Lando M, Fjeldbo CS, Wilting SM, et al. Interplay between promoter methylation and chromosomal loss in gene silencing at 3p11-p14 in cervical cancer. Epigenetics. 2015;10:970–980. doi:10.1080/15592294.2015.1085140
   PubMed Web of Science ®Google Scholar
• Ku GM, Pappalardo Z, Luo CC, German MS, McManus MT. An sirna screen in pancreatic beta cells reveals a role for gpr27 in insulin production. PLoS Genet. 2012;8:e1002449. doi:10.1371/journal.pgen.1002449
   PubMed Web of Science ®Google Scholar
• Nath AK, Ma J, Chen -Z-Z. Genetic deletion of gpr27 alters acylcarnitine metabolism, insulin sensitivity, and glucose homeostasis in zebrafish. FASEB J. 2020;34:1546–1557. doi:10.1096/fj.201901466R.
   PubMed Web of Science ®Google Scholar
• Wei X, Li S, He J, et al. Tumor-secreted pai-1 promotes breast cancer metastasis via the induction of adipocyte-derived collagen remodeling. Cell Commun Signal. 2019;17:58. doi:10.1186/s12964-019-0373-z
   PubMed Web of Science ®Google Scholar
• Li H, Sun L, Li H, et al. Dt-13 synergistically enhanced vinorelbine-mediated mitotic arrest through inhibition of foxm1-bicd2 axis in non-small-cell lung cancer cells. Cell Death Dis. 2017;8:e2810. doi:10.1038/cddis.2017.218
   PubMed Web of Science ®Google Scholar
• Jin C, Shi L, Li K, et al. Mechanism of tumor‑derived extracellular vesicles in regulating renal cell carcinoma progression by the delivery of malat1. Oncol Rep. 2021;46:187. doi:10.3892/or.2021.8138
   PubMed Web of Science ®Google Scholar
• Riss T, Niles A, Moravec R, et al. Cytotoxicity assays: in vitro methods to measure dead cells. In: Markossian S, Grossman A, Brimacombe K, Arkin M, Auld D, Austin CP, editors. Assay Guidance Manual. Bethesda (MD): Eli Lilly & Company and the National Center for Advancing Translational Sciences; 2004.
   Google Scholar
• Suski JM, Braun M, Strmiska V, et al. Targeting cell-cycle machinery in cancer. Cancer Cell. 2021;39:759–778. doi:10.1016/j.ccell.2021.03.010
   PubMed Web of Science ®Google Scholar
• Matsui T, Chiyo T, Kobara H, et al. Telmisartan inhibits cell proliferation and tumor growth of esophageal squamous cell carcinoma by inducing s-phase arrest in vitro and in vivo. Int J Mol Sci. 2019;20:3197. doi:10.3390/ijms20133197
   PubMed Web of Science ®Google Scholar
• Sharma GP, Gurung SK, Inam A, et al. Cid-6033590 inhibits p38mapk pathway and induces s-phase cell cycle arrest and apoptosis in du145 and pc-3 cells. Toxicol in Vitro. 2019;60:420–436. doi:10.1016/j.tiv.2019.06.003
   PubMed Web of Science ®Google Scholar
• Gopinathan L, Tan SLW, Padmakumar VC, et al. Loss of cdk2 and cyclin a2 impairs cell proliferation and tumorigenesis. Cancer Res. 2014;74:3870. doi:10.1158/0008-5472.CAN-13-3440. 
   PubMed Web of Science ®Google Scholar
• Pistritto G, Trisciuoglio D, Ceci C, et al. Apoptosis as anticancer mechanism: function and dysfunction of its modulators and targeted therapeutic strategies. Aging. 2016;8:603–619. doi:10.18632/aging.100934
   PubMedGoogle Scholar
• Hossain MS, Mineno K, Katafuchi T. Neuronal orphan g-protein coupled receptor proteins mediate plasmalogens-induced activation of erk and akt signaling. PLoS One. 2016;11:e0150846. doi:10.1371/journal.pone.0150846
   PubMed Web of Science ®Google Scholar
• Moon H, Ro SW. Mapk/erk signaling pathway in hepatocellular carcinoma. Cancers. 2021;13:3026. doi:10.3390/cancers13123026
   PubMed Web of Science ®Google Scholar
• Nath AK, Ma J, Chen ZZ, et al. Genetic deletion of gpr27 alters acylcarnitine metabolism, insulin sensitivity, and glucose homeostasis in zebrafish. FASEB j. 2020;34:1546–1557. doi:10.1096/fj.201901466R
   PubMed Web of Science ®Google Scholar
• Chopra DG, Yiv N, Hennings TG, Zhang Y, Ku GM. Deletion of gpr27 in vivo reduces insulin mrna but does not result in diabetes. Sci Rep. 2020;10:5629. doi:10.1038/s41598-020-62358-4
   PubMed Web of Science ®Google Scholar
• Satriano L, Lewinska M, Rodrigues PM, et al. Metabolic rearrangements in primary liver cancers: cause and consequences. Nat Rev Gastro Hepat. 2019;16:748–766. doi:10.1038/s41575-019-0217-8
   PubMed Web of Science ®Google Scholar
• Chandrashekar DS, Bashel B, Balasubramanya SAH, et al. Ualcan: a portal for facilitating tumor subgroup gene expression and survival analyses. Neoplasia. 2017;19(8):649–658. doi:10.1016/j.neo.2017.05.002
   PubMed Web of Science ®Google Scholar
• Gopinathan L, Tan SL, Padmakumar VC, et al. Loss of cdk2 and cyclin a2 impairs cell proliferation and tumorigenesis. Cancer Res. 2014;74:3870–3879. doi:10.1158/0008-5472.CAN-13-3440
   PubMed Web of Science ®Google Scholar
• Evan GI, Vousden KH. Proliferation, cell cycle and apoptosis in cancer. Nature. 2001;411:342–348. doi:10.1038/35077213
   PubMed Web of Science ®Google Scholar
• Liu F, Yang X, Geng M, et al. Targeting erk, an achilles’ heel of the mapk pathway, in cancer therapy. Acta Pharm Sin B. 2018;8:552–562. doi:10.1016/j.apsb.2018.01.008
   PubMed Web of Science ®Google Scholar
• Lee S, Rauch J, Kolch W. Targeting mapk signaling in cancer: mechanisms of drug resistance and sensitivity. Int J Mol Sci. 2020;21. doi:10.7150/ijms.39074
   PubMed Web of Science ®Google Scholar
• Lee C, Cheung ST. Stat3: an emerging therapeutic target for hepatocellular carcinoma. Cancers. 2019;11:1646. doi:10.3390/cancers11111646
   PubMed Web of Science ®Google Scholar
• Gough DJ, Corlett A, Schlessinger K, et al. Mitochondrial stat3 supports ras-dependent oncogenic transformation. Science. 2009;324:1713–1716. doi:10.1126/science.1171721
   PubMed Web of Science ®Google Scholar